American International Holdings CORP.: insider trades · United States · SEC (Form 4)

About American International Holdings CORP.

American International Holdings Corp. (AMIH) is a U.S.-listed company with SEC reporting activity and a history of trading in the OTC ecosystem rather than on NYSE or NASDAQ. For international investors, it should be viewed as a very small-cap, event-driven issuer whose business profile has evolved materially over time. The company’s operating footprint has been disclosed in SEC filings with addresses in Plano, Texas, and later Electra, Texas, reflecting a changing corporate structure and a series of reorganizations. AMIH has gone through multiple shifts in control and strategic focus, which is a key point for assessing the stock: the company is not a long-established healthcare platform with stable, scaled operations, but rather a transformation story. In its more recent filings and communications, AMIH has positioned itself around healthcare, wellness and technology-enabled services. A central element of this strategy was the launch of ZipDoctor in 2020, a monthly subscription telemedicine platform offering customers 24/7 access to board-certified physicians and licensed mental and behavioral health counselors. Earlier company disclosures also described a broader portfolio spanning virtual health platforms, subscriber-based primary care and concierge medicine plans, preventive care solutions, mental and behavioral health services, and a proprietary life-coaching platform. The company has emphasized both direct-to-consumer and business-to-business distribution channels, with an acquisition-led strategy aimed at buying and growing businesses that can generate durable cash flow and attractive returns. Historically, AMIH has been a company in motion. SEC filings show repeated restructurings, shifts in management, and changes in control, including a notable 2023-2024 share-exchange and governance reset. That matters because the company’s current business mix and long-term execution risk are still being shaped by those corporate events. From a competitive standpoint, AMIH appears to compete in niche segments of telehealth and digital wellness rather than against the largest U.S. healthcare platforms on scale or brand strength. Its value proposition has centered on subscription access, convenience, and digital delivery of care and coaching services, rather than on a broad hospital, pharmacy or insurance footprint. For French, Belgian and Swiss investors, the key takeaway is that AMIH is a speculative U.S. healthcare/technology micro-cap with limited operating visibility but meaningful corporate change potential. The company’s product set remains focused on telemedicine, mental health counseling, primary-care subscriptions and wellness-oriented digital services. Recent noteworthy developments include management changes, restructuring steps, and ownership transitions, all of which can have a significant impact on future strategy and dilution risk. In short, AMIH is best understood as a small U.S. healthcare technology holding company in transition, listed under SEC reporting requirements, with the United States as its home market and NYSE/NASDAQ not confirmed in the available filings.